External use of Mirabilite combined with Lactulose improves postoperative gastrointestinal mobility among older

Wenyan Pan1, Shining Cai1, Jos M Latour2

  • 1Department of Nursing, Zhongshan Hospital, Fudan University, Shanghai, China.

Journal of Advanced Nursing
|November 24, 2020
PubMed
Abstract

Insights

Mirabilite combined with Lactulose improved postoperative gastrointestinal mobility in older patients. This combination therapy enhanced bowel function recovery and reduced hospital stays for surgical intensive care unit patients.

Area of Science:

  • Gastroenterology
  • Surgical Critical Care
  • Pharmacology

Background:

  • Postoperative gastrointestinal tract dysfunction (PGITD) is a common complication in older patients following abdominal surgery.
  • Effective interventions are needed to improve recovery and reduce patient suffering.

Purpose of the Study:

  • To evaluate the feasibility and efficacy of using Mirabilite combined with Lactulose for older patients experiencing PGITD.
  • To assess the impact of this combined therapy on gastrointestinal motility and patient outcomes.

Main Methods:

  • A retrospective observational cohort study comparing patients who received Mirabilite + Lactulose with those who received Lactulose alone.
  • Analysis of medical records from surgical intensive care unit patients aged over 60 years with PGITD between January 2017 and December 2018.

Main Results:

  • The Mirabilite + Lactulose group showed a significantly higher recovery rate of bowel sounds (62.16% vs. 37.63%) and a greater incidence of flatus or defecation (70.27% vs. 46.24%).
  • This combination therapy led to significant reductions in abdominal girth, inter-abdominal pressure, and pain scores compared to Lactulose alone.
  • Patients receiving Mirabilite + Lactulose experienced a shorter hospital stay (12.5 vs. 13.9 days).

Conclusions:

  • External application of Mirabilite combined with Lactulose is a feasible and effective intervention for improving postoperative gastrointestinal mobility in older intensive care patients.
  • This painless, safe, and easily implementable therapy offers a valuable option for alleviating suffering in postoperative patients with PGITD.

Related Concept Videos

Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
777
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
321
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
524
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
444
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
312
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
316